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Transcriptional mediators of cell stress pathways,
including HIF1a, ATF4, and p53, are key to normal
development and play critical roles in disease,
including ischemia and cancer. Despite their impor-
tance, mechanisms by which pathways mediated
by these transcription factors interact with one
another are not fully understood. In addressing the
controversial role of HIF1a in cardiomyocytes (CMs)
during heart development, we discovered a mid-
gestational requirement for HIF1a for proliferation
of hypoxic CMs, involving metabolic switching
and a complex interplay among HIF1a, ATF4, and
p53. Loss of HIF1a resulted in activation of ATF4
and p53, the latter inhibiting CM proliferation.
Bioinformatic and biochemical analyses revealed
unexpected mechanisms by which HIF1a intersects
with ATF4 and p53 pathways. Our results highlight
previously undescribed roles of HIF1a and interac-
tions among major cell stress pathways that could
be targeted to enhance proliferation of CMs in
ischemia and may have relevance to other diseases,
including cancer.
INTRODUCTION
To fulfill their critical blood-pumping activity, cardiomyocytes
(CMs) acquire profound structural and biochemical modifica-
tions during their maturation. Mature CMs are withdrawn from
the cell cycle, display an intricate contractile apparatus, and
contain large numbers of mitochondria required to provide, via
oxidative phosphorylation (OXPHOS), sufficient ATP for contrac-
tile activity. In contrast to their mitotically withdrawn adult coun-
terparts, fetal CMs (fCMs) have the capacity to both contract andDeveproliferate. Understanding the pathways that regulate prolifera-
tion of fCMs will allow a better understanding of congenital heart
disease, the most prevalent human birth defect, and may also
provide potential pathways for triggering adult CM regeneration.
To identify regulators of fCM proliferation, we undertook an
in silico screen that suggested that hypoxia inducible factor
1a (HIF1a), a transcription factor (TF) activated by low oxygen,
mediates a pro-proliferative response during cardiac develop-
ment. In well-perfused tissues, HIF1a subunits are hydroxylated
and targeted for proteasomal degradation via VHL-mediated
ubiquitination. Hypoxia ([O2] < 5%) disrupts HIF1a ubiquitina-
tion, leading to its stabilization and association with HIF1b
(ARNT) to promote a pro-survival response based on induction
of genes involved in processes such as energy metabolism
and angiogenesis (Denko, 2008; Pugh and Ratcliffe, 2003).
HIF1a is typically activated in poorly vascularized solid tumors,
and mutations in Vhl that disrupt HIF1a degradation cause von
Hippel-Lindau disease, an inherited disorder characterized by
predisposition to several tumors (Denko, 2008).
Under conditions of prolonged exposure to hypoxia, pro-sur-
vival effects of HIF1a can be blocked by activation of p53, a TF
that promotes cell death and senescence (Schmid et al., 2004).
p53 blocks the cell cycle, at least in part, by inducing expression
of members of the CIP/KIP family (Schmid et al., 2004). Proteins
of this family (p21, p27, and p57) inhibit cyclin-dependent
kinases and block G1/S progression (Kochilas et al., 1999). Acti-
vation of p53 blocks HIF1a signaling by at least two distinct
mechanisms: p53-induced degradation of HIF1a and competi-
tion for the limiting transcriptional co-activator p300 (Schmid
et al., 2004). On the other side of this antagonistic relationship,
HIF1a transcriptional activity prevents post-translational activa-
tion of p53 by inducing expression ofMif (Fingerle-Rowson et al.,
2003; Hudson et al., 1999; Welford et al., 2006).
Hypoxic stress also results in activation of PERK and conse-
quent increased translation of ATF4, another major stress-
responsive TF that plays a role in cancer by regulating redox
balance, protein folding, amino acid uptake and metabolism,
and angiogenesis (Fels and Koumenis, 2006; Han et al., 2013;lopmental Cell 33, 507–521, June 8, 2015 ª2015 Elsevier Inc. 507
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Harding et al., 2003; Roybal et al., 2005). Despite being induced
in response to similar stimuli, how HIF1a and ATF4 pathways
might mutually regulate each other remains unexplored.
In addition to a prominent role in tumorigenesis, oxygen levels
play critical roles in cardiogenesis, as highlighted by the recent
finding that hyperoxia, reactive oxygen species (ROS), and
ensuing DNA damage induce neonatal CM cell-cycle withdrawal
(Puente et al., 2014). However, the role of hypoxia and HIF1a in
mammalian cardiac development has been controversial and
thus poorly understood. Three Hif1a null alleles, all targeting
exon 2 that encodes the HIF1a DNA binding domain, were inde-
pendently generated by distinct groups (reviewed by Dunwoo-
die, 2009). Regardless of the allele considered, mutant embryos
die around E10 and display severe vascular and placental de-
fects. Interestingly, phenotypic coherence is lost when cardiac
phenotypes are analyzed. Two of the Hif1a null alleles produce
mutants with underdeveloped hearts, while a third allele,
Hif1atm1Jhu, produces mutants exhibiting myocardial hyperpla-
sia (Dunwoodie, 2009).
The early lethality of global Hif1a knockouts (KOs) precludes
study of potential roles of HIF1a in later stages of cardiogenesis.
Furthermore, severe placental and vascular defects of global
KOs make it difficult to ascertain whether reported cardiac
defects are a primary or secondary phenotype. The generation
of a fourth Hif1a allele in which exon 2 is flanked by loxP sites
enabled spatial and temporal regulation of Hif1a ablation (Ryan
et al., 2000). Using this floxed allele and the Mlc2v-Cre line,
two groups independently ablated Hif1a in ventricular CMs.
Here again, results were inconsistent. When two floxed Hif1a
alleles were used, conditional KOs did not present any develop-
mental abnormalities (Huang et al., 2004). In contrast, when the
breeding strategy included one floxedHif1a allele and the hyper-
proliferative Hif1atm1Jhu null allele, mutant embryos exhibited
myocardial hyperplasia and lethality between E11.5 and E12
(Krishnan et al., 2008).
Driven by our bioinformatics results, and to resolve current
discrepancies in the literature, we investigated the role of
HIF1a in murine cardiogenesis. Our results revealed previously
undescribed spatiotemporal dynamics of HIF1a nuclear localiza-
tion in developing myocardium that critically regulate a specific
window of fCM proliferation prior to completion of cardiac angio-
genesis. Using the Hif1a floxed allele (Ryan et al., 2000), we
found that efficient depletion of HIF1a in fCMs could be achieved
only by using an early acting Cre, Nkx2-5-Cre. Ablation of Hif1a
with Nkx2-5-Cre resulted in embryonic lethality between E14.5
and E17.5, with mutant hearts exhibiting hypoplastic ventricles
and ventricular septal defects (VSDs).
RNA sequencing (RNA-seq) and genome-wide chromatin
immunoprecipitation (ChIP) sequencing (ChIP-seq) analyses of
mutant and control hearts demonstrated that HIF1a regulated
fCM proliferation by activation or repression of key downstreamFigure 1. Bioinformatics Prediction of TFs that Regulate fCM Prolifera
(A) On the basis of common expression trends, transcripts differentially expressed
were grouped into nine distinct clusters. Enriched Gene Ontology terms revealed
associated with cell cycle, strongly expressed in development and attenuated p
(B) Analysis for enrichment of evolutionarily conserved TF binding sites within the
fCM proliferation.
See also Table S1.
Devetarget genes. As observed in other contexts, we have found that,
in fCMs, HIF1a coordinately represses and activates genes to
effectmetabolic switching to a glycolytic state, providing biosyn-
thetic substrates that facilitate proliferation (Vander Heiden et al.,
2009). Of note, we also defined a role for HIF1a in promoting cell
proliferation by direct repression of cell-cycle inhibitors of the
CIP/KIP family. Additionally, our findings have revealed interplay
between HIF1a and p53 pathways during cardiogenesis, as well
as previously unsuspected interactions between HIF1a and the
ATF4 cellular stress response. These interactions betweenmajor
cellular stress pathways may be targeted to enhance prolifera-
tion of CMs in settings of pediatric cardiac hypoplasia or in adult
ischemic disease and are likely to have relevance in the setting of
other diseases, including cancer.
RESULTS
Bioinformatics and Comparative Genomics Analyses
Suggest HIF1a as a Candidate Regulator of fCM
Proliferation
We developed a two-step bioinformatics and comparative
genomics analysis to identify TFs that might play a role in heart
development and adult cardiac remodeling. We compared 148
Affymetrix microarrays of mouse ventricular tissue isolated
from multiple physiological and pathological situations (Table
S1) and clustered transcripts to identify those exhibiting similar
expression dynamics (Figure 1A). Cluster 1 grouped genes highly
expressed in developing heart, downregulated perinatally, and
re-induced, to a limited extent, in pathological situations. Func-
tional annotation of this cluster revealed significant enrichment
for transcripts encoding proteins involved in cell-cycle regula-
tion, DNA replication, and cytokinesis (Figure 1A).
Whole-Genome RVista was then used to predict which TFs
might control expression of these genes (Dubchak et al., 2013).
For this analysis, the 5 kb proximal promoter regions of all cluster
1 genes were scanned for statistical enrichment of evolutionarily
conserved (human/mouse) TF binding sites. Several TF binding
motifs were highly enriched in these promoters, suggesting
that corresponding binding TFs might regulate fCM proliferation
(Figure 1B). From these, HIF1a was the most significantly
enriched binding site (p < 1022). HIF1a has been shown to
promote, via Vegf induction, angiogenesis in adult hypertrophic
remodeling (Sano et al., 2007) and in zebrafish is required for
CM proliferation after ventricular amputation (Jopling et al.,
2012). However, the role of HIF1a during cardiogenesis remains
highly controversial (Dunwoodie, 2009).
Distinct Temporal and Spatial Subcellular Localization
of HIF1a in fCMs
To investigate if HIF1a protein is present and therefore possibly
playing a role in fCMs, immunohistochemistry for HIF1a wastion
in cardiac development or adult remodeling (physiological and/or pathological)
biological processes associated with each cluster. Cluster 1 contained genes
erinatally.
proximal promoters of all cluster 1 genes, revealing candidate TF regulators of
lopmental Cell 33, 507–521, June 8, 2015 ª2015 Elsevier Inc. 509
performed on embryonic mouse hearts at several stages of
development. Antibody specificity was tested in global Hif1a
KOs. A null allele of Hif1a, designated Hif1aD, was generated
by floxing out the conditional Hif1a allele (Ryan et al., 2000),
and as expected, breeding ofHif1aD/WT heterozygotes produced
no viable Hif1aD/D progeny. Analysis of timed pregnancies
revealed no homozygous mutants from E10.5 onward. E9.5
mutants were much smaller than littermates, exhibiting reduced
proliferation, markedly increased apoptosis of neuronal and
mesenchymal tissues, and an extremely small, unlooped heart
(Figures S1A–S1F). Histological analyses of these mutants with
anti-HIF1a antibody produced no detectable signal, in contrast
to results from wild-type (WT) littermates, demonstrating anti-
body specificity (Figures S1C and S1D).
The recently looped E9.5 heart is composed of an inner layer of
endocardial cells surrounded by a single layer of fCMs. At this
stage, robust levels of HIF1a protein were detected in the devel-
opingheart, but, intriguingly,mostHIF1awas retainedoutside the
nucleus, regardless of the cell type considered (Figures 2A–2C).
At E12.5, the interventricular septum (IVS) is relatively well
developed, and the ventricular free walls are composed of two
distinct domains, the trabeculae and the compact zone. At this
stage, robust levels of HIF1a were detected in nuclei of fCMs
located in the core of the developing septum and outermost
layers of the compact zone, but not in nuclei of trabecular
fCMs or fCMs located in the innermost layers of compact
myocardium (Figures 2D–2F).
From E12.5, endothelial precursors of the coronary vascula-
ture progressively invade the myocardial wall, connecting to
the aorta around E14.0 to perfuse developing myocardial walls
with oxygenated blood (Figures S1G and S1H). This angiogenic
process is gradual and takes place in an epicardial-to-endocar-
dial direction. At E14.5, in regions of themyocardial wall adjacent
to endocardium or containing coronary vasculature, myocardial
HIF1a was observed outside the nucleus in cytoplasmic aggre-
gates (Figures 2G–2I). Nuclear HIF1a, however, was consistently
observed in fCMs within non-vascularized regions of myocar-
dium (arrowheads in Figure 2I). At E17.5, the coronary vascular
system has colonized the entire heart, and HIF1a was detected
in cytoplasmic aggregates (Figures 2J–2L).
Correlation between the timing of perfusion of the coronary
wall (as assessed by fluorescent microsphere injection; Figures
S1G and S1H) and spatiotemporal dynamics of nuclear accumu-
lation of HIF1a in fCMs (Figure 2) strongly suggested availability
of oxygenated blood as a major regulator of HIF1a subcellular
localization during cardiogenesis, without excluding other fac-
tors from playing a role in this process. Importantly, at develop-
mental time points in which strong nuclear HIF1a could be
detected, nuclear presence of this TF correlated with high fCM
proliferation rates (Figures S1I–S1L). Notably, fCMs were the
only cell type of the developing heart that displayed robust
nuclear localization of HIF1a. Epicardium, endocardium, and
mesenchymal cells of the cushions exhibited accumulation of
HIF1a in cytoplasmic clusters.
Early Myocardial Ablation of Hif1a Produces Severe
Cardiac Defects and Embryonic Lethality
After our bioinformatics prediction of a role for HIF1a in promot-
ing fCM proliferation and the observation of nuclear HIF1a in510 Developmental Cell 33, 507–521, June 8, 2015 ª2015 Elsevier Inhighly proliferative subsets of mid-gestational fCMs, we investi-
gated the potential role of this TF in fCM proliferation. As we had
observed HIF1a protein present in heart from as early as E9.5
and as HIF1a is stabilized in hypoxic conditions, we hypothe-
sized that early and efficient myocardial ablation is critical for
effective loss of HIF1a in fCMs. Commonly used myocardial
Cres are Nkx2-5-Cre, aMhc-Cre, and Mlc2v-Cre, with expres-
sion of each Cre being activated at distinct developmental time
points. As demonstrated in Figures S2A–S2F, we found that
the Nkx2-5-Cre was the only Cre that effectively activated a
reporter throughout the myocardium by E8.5. At the same stage,
aMhc-Cre or Mlc2v-Cre produced much weaker and mosaic
reporter activation. We used both aMhc-Cre and Nkx2-5-Cre
to ablate the floxed Hif1a allele (Ryan et al., 2000) in fCMs. To
ensure the most efficient recombination possible, the null Hif1aD
allele, generated by germline ablation of the floxed allele, was
included in all crosses.
Results revealed that aMhc-Cre;Hif1aD/fl mutants were viable,
born at expected Mendelian ratios, and displayed normal sur-
vival at 3 months (Table 1). In contrast, ablation of Hif1a driven
by Nkx2-5-Cre resulted in embryonic lethality, with only 3 out
of an expected 21 mutants found dead at P0 and no mutants
recovered at weaning. Consistent with these results, histological
analyses of E13.5 embryos revealed that Nkx2-5-Cre, but not
aMhc-Cre, resulted in effective depletion of HIF1a protein in
developing fCMs (Figures S2G–S2J). At E13.5, even in Nkx2-
5-Cre;Hif1aD/fl mutants (hereafter simply designated as Hif1a
cKOs), only 73% (8 of 11) of the mutants displayed a complete
KO, with the remaining 27% exhibiting reduced, but not absent,
HIF1a (Figures S2I and S2J).
In comparison with stage-matched control littermates,
E12.5 Hif1a cKOs with efficient HIF1a protein depletion dis-
played smaller IVS (Figure 3A). At E14.5, in addition to
prominent VSDs, mutant hearts exhibited thinner ventricular
walls (Figures 3A–3C). These defects were accompanied by a
significant decrease in the rate of fCM proliferation as assessed
by EdU incorporation (Figure 3D). Quantification of EdU-posi-
tive fCMs demonstrated that in wild-type (WT) septa and left
ventricular compact myocardium approximately 30% of
fCMs underwent DNA synthesis through the course of a 2 hr
period. In mutant hearts, these rates significantly decreased
to 18.35% ± 1.33% in the septum and 22.76% ± 1.87%
(p < 0.01) in the ventricular compact wall (Figure 3E). No
changes in apoptosis were detected by cleaved caspase-3 in
mutant hearts (Figure 3F). Consequent to these defects, the
majority of Hif1a cKOs died between E14.5 and E17.5 (Table
2). At E17.5, out of 12 expected, only 3 mutants (25%) were
recovered alive, all exhibiting abnormal ventricular architecture
(Figures S2K–S2N). Similar frequencies of embryos with incom-
plete HIF1a depletion at E13.5 and Hif1a cKOs recovered at
E17.5 (27% and 25%, respectively) suggested that mutants
that reached this late gestational stage were embryos in which
Nkx2-5-Cre activity had not resulted in effective depletion of
HIF1a.
Because Nkx2-5-Cre ablates HIF1a protein in fCM and
non-fCM populations within the heart, it was possible that non-
fCM-specific effects could contribute to the lethal phenotype.
However, the absence of nuclear accumulation of HIF1a in
non-fCMcell populations throughout the relevant developmentalc.
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Figure 2. Spatiotemporal Dynamics of HIF1a Protein during Cardiogenesis
(A–C) In E9.5 fCMs, HIF1a was retained in extra-nuclear aggregates (arrow in C).
(D–F) At E12.5, HIF1a accumulated in nuclei of fCMs located in non-vascularized areas of the myocardium, including fCMs of the inner core of the IVS and
outermost layers of the compact wall (arrowheads).
(G–I) At E14.5, the coronary vascular system has colonized most of the ventricular free walls. At this stage, most fCMs displayed cytoplasmic HIF1a (arrow in I),
and only a small fraction of fCMs located between the endocardium and the leading edge of the progressing coronary vasculature exhibited significant levels of
nuclear HIF1a (boxed area in H and arrowheads in I).
(J–L) At E17.5, the coronary vascular system has colonized the entire heart and HIF1a was no longer detectable in the nucleus of fCMs, being present only in
cytoplasmic aggregates (arrows in L).
To allow better visualization of the location of HIF1a relative to the coronary endothelium, all 403 images are shown in two distinct panels: a four-color merge and
a red-and-green-only merge. Boxed areas are imaged in higher magnifications. Scale bars represent 500 mm in the 103montages and 20 mm in all other panels.
See also Figure S1.period suggested that the observed phenotype resulted from an
fCM-autonomous requirement for HIF1a. Supportive of this
conclusion, we used Wt1-Cre and Tie2-Cre to generate epicar-
dial- and endocardial-specific Hif1a conditional KOs, neither
resulting in lethality (Table 1).DeveGene Expression Profiling of Hif1a cKO Hearts
To identify molecular pathways responsible for reduced fCM
proliferation in Hif1a cKOs, we performed RNA-seq analysis of
RNA extracted from E12.5 hearts of Nkx2-5WT/Cre;Hif1aD/fl
mutants and Nkx2-5WT/Cre;Hif1aWT/fl littermate controls. Fromlopmental Cell 33, 507–521, June 8, 2015 ª2015 Elsevier Inc. 511
Table 1. List of Cre Lines Used to Promote Conditional KO of Hif1a, Their Target Cellular Populations, and Resulting Genotype
Frequencies at Birth
Genotype Distribution at Birth (%)
Cre Target Population Number of Litters Number of Animals
Cre Positive Cre Negative
Hif1aD/fl Hif1aWT/fl Hif1aD/fl Hif1aWT/fl
aMhc myocardium 9 71 32.39 26.76 18.31 22.54
Nkx2-5 myocardium 15 83 3.61a 27.71 34.94 33.73
Wt1 epicardium and derivatives 7 41 26.83 24.39 26.83 21.95
Tie2 endocardium; cushions; endothelium 7 57 24.56 31.58 24.56 19.30
aPups found dead at P0.this analysis, 14,502 protein-coding genes were expressed in
both mutant and control hearts. Of these, 494 and 957 were
significantly (jFoldj > 20%, p < 0.05) up- or downregulated,
respectively, in mutant hearts relative to controls (Figure 4A;
Tables S2A and S2B). Clustering of differentially expressed
genes by molecular function using the Reactome database
enabled an overview of known cellular pathways most severely
altered in mutant hearts. Consistent with known roles of HIF1a,
some of the most significantly downregulated categories in
mutant hearts were associated with glycolysis and glucose
metabolism (Figure 4B; Table S2F). Less expected was
observed enrichment for processes associated with extracellular
matrix (ECM) organization.
Similar analysis of upregulated genes (Figure 4B; Table S2F)
demonstrated striking enrichment of categories related to
tRNA aminoacylation, amino acid synthesis and interconversion,
amino acid transport, unfolded protein response, and respiratory
electron transport.
Identification of Direct Targets of HIF1a in E12.5 Hearts
Having determined a wide array of genes displaying altered
expression upon HIF1a depletion, direct HIF1a targets were
predicted by integrating transcriptomic results with genome-
wide assessment of HIF1a binding sites in wild-type (WT)
E12.5 hearts (ChIP-seq). Two independent ChIP-seq experi-
ments resulted in 17,289 peaks significantly enriched over input
reads, indicating putative HIF1a binding sites across the
genome (Table S3). Motif analysis of these peaks demonstrated
that HIF1amotifs were the most significantly enriched sequence
(p = 10281), indicating successful pull-down of HIF1a-bound
loci.
Intragenic peaks with a minimum peak score of 3.5 were as-
signed to the protein-coding gene with the nearest transcrip-
tional start site. Filtering for genes actively expressed in E12.5
hearts resulted in a list of 2,027 genes (Table S2C). To identify
direct HIF1a targets (genes bound by HIF1a and modulated
upon HIF1a depletion), this list was compared with the list of
1,451 genes regulated in mutant hearts. This analysis suggested
115 genes directly activated and 51 genes directly repressed by
HIF1a (Figure 4C; Tables S2D and S2E). The fact that HIF1a acti-
vated more than twice as many genes as it repressed confirmed
this TF acts preferentially as a transcriptional activator in fetal
heart. Thirty percent of downregulated and 39.2% of upregu-
lated HIF1a targets did not contain a minimal HIF binding motif
in the associated peak (Figure S3A), suggesting that HIF1a-me-
diated gene regulation is not always dependent on the presence512 Developmental Cell 33, 507–521, June 8, 2015 ª2015 Elsevier Inof a classic hypoxia-responsive element (HRE), consistent with
previous observations (Tanimoto et al., 2010).
To gain insight into co-factors other than HIF1b that might be
cooperating with HIF1a to either activate or repress gene
expression, the vicinities (±100 bp) of HIF1a ChIP-seq peaks
corresponding to targets modulated in Hif1a cKO hearts were
screened for enrichment in known TF binding sequences (Ta-
ble S4). This analysis was independently performed for peaks
with and peaks without HRE. Among peaks containing an
HRE, enrichment in SMAD binding sites was observed regard-
less of the nature of regulation promoted by HIF1a. Enrichment
in binding sites for Sp1, a known HIF1a partner (Miki et al.,
2004), was observed in peaks corresponding to genes
activated by HIF1a. Binding sites for ATF4 were the most en-
riched motif in peaks corresponding to targets repressed by
HIF1a.
Among peaks devoid of an HRE, a significant enrichment in
binding sites for members of the ETS family was observed,
regardless of the nature of regulation exerted by HIF1a. Interest-
ingly, among peaks corresponding to genes activated by HIF1a,
a significant enrichment in binding sites of cardiac specific TFs
(MEF2c, MEF2a, and GATA4) was observed, suggesting that
HIF1amay associate with tissue-specific TFs to activate expres-
sion of direct targets.
HIF1a Directly Regulates Glycolysis, OXPHOS, and
Collagen Fibrillogenesis
Perhaps not surprisingly, in view of known roles of HIF1a in other
cell types (Denko, 2008), functional annotation of direct targets
positively regulated by HIF1a (Figure 4D) revealed a pivotal role
in the regulation of energy metabolism. Examination of direct
targets listed in Table S2D revealed that HIF1a regulated the
glycolytic potential of fCMs by direct activation of 13 enzymes
or carriers directly involved in each step of glycolysis (Slc2a3,
Hk2, Pfkl, Pfkp, Aldoa, Aldoc, Gapdh, Tpi1, Pgk1, Pgam1,
Eno1, Pkm2, and Ldha; Figures S3B and S3C). In addition to
the critical role in promoting glycolysis, detailed analysis of direct
HIF1a targets modulated in cKO hearts (Tables S2D and S2E)
demonstrated that HIF1a acted at multiple levels to reducemito-
chondrial biomass and regulate OXPHOS potential of hypoxic
fCMs (Table S2G). These included activation of the Mxi1 gene,
encoding a known inhibitor of C-MYC-mediated mitochondrial
biogenesis (Zhang et al., 2007). HIF1a-mediated induction of
glycolysis and reduction in OXPHOS primes hypoxic fCMs to
adapt their energy metabolism to low oxygen tension. These ad-
aptations are critical for sustained ATP production and to avoidc.
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Figure 3. Efficient Ablation of HIF1a in fCMs Results in Hypoplasia and Arrested Cardiac Development
(A) At E12.5, efficient depletion of HIF1a mediated by Nkx2-5-Cre resulted in shortened IVS (arrow in middle). At E14.5 (bottom), mutant hearts exhibited VSDs
(asterisk) and hypoplastic ventricles.
(B) Quantification of septal length in medial sections of control and cKO hearts.
(C) Quantification of left ventricular wall thickness in E14.5 hearts.
(D) E11.5 was the first stage at which a clear decrease in HIF1a protein levels was identified in Hif1 cKO hearts (top). At E12.5, lack of HIF1a resulted in markedly
lower numbers of EdU positive nuclei (2 hr pulse) in the IVS (middle) and compact ventricular myocardium (bottom).
(E) Quantification of proliferative defects in distinct compartments of E12.5 hearts as a ratio of EdU-positive fCMs/total fCMs.
(legend continued on next page)
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Table 2. Genotype Frequencies, at Distinct Stages of Embryonic
Development, for Conditional KO of Hif1a by Nkx2-5-Cre
Genotype Distribution (%)
Stage
Number of
Litters
Number of
Animals
Cre Positive Cre Negative
Hif1aD/fl Hif1aWT/fl Hif1aD/fl Hif1aWT/fl
E12.5 18 129 22.48 33.33 24.81 19.38
E13.5 6 52 21.15 15.38 36.54 26.92
E14.5 5 34 29.41 23.53 23.53 23.53
E17.5 7 49 6.12 32.65 24.49 36.73
Total 36 264excessive ROS production by oxygen-depleted mitochondria
(Semenza, 2013). Comparison of control and mutant E12.5 left
ventricular compact walls by immunohistochemistry confirmed
that Hif1a cKO fCMs failed to adapt their OXPHOS potential to
hypoxic conditions, displaying increased mitochondrial biomass
(anti-COX IV staining) and increased DNA damage, as revealed
by anti-pH2AX staining (Figure 4E).
Consistent with recent observations in fibroblasts (Gilkes
et al., 2013), our results indicated that in fCMs, HIF1a directly
promoted expression of two genes encoding enzymes required
for collagen fiber assembly: Plod2 and P4ha1.
Interestingly, although our ChIP-seq data suggested that
HIF1a bound to Vegf and Epo loci, RNA-seq indicated that the
expression of these genes was not changed in Hif1a cKO hearts
(Figure S3D).
HIF1a Directly Represses Genes Encoding Cell-Cycle
Inhibitors and Effectors of a Cell Stress Response
Of direct relevance to observed fCM hypoplasia in Hif1a cKOs,
functional clustering of the 51 direct targets upregulated in mu-
tants, thus normally repressed by HIF1a in WT hearts, resulted
in a significant enrichment for genes associated with cell-cycle
regulation (Figure 4D). Examination of the complete list (Table
S2E) suggested that HIF1a directly repressed expression of
three well-characterized cell-cycle inhibitors: Cdkn1a (p21),
Cdkn1c (p57), and Tob2. Further analysis of direct HIF1a targets
upregulated in mutant hearts also demonstrated enrichment
for genes encoding critical effectors of the unfolded protein
response: Atf4, Herpud1, and Ppp1r15a (Figure 4D; Table
S2E). Immunofluorescence analysis of the compact ventricular
wall of E12.5 hearts confirmed upregulation and nuclear accu-
mulation of p57 and ATF4 in Hif1a cKO fCMs (Figure 4E).
Multiple Genes Aberrantly Upregulated in Hif1a cKO
Hearts Are ATF4 Targets
ChIP-seq results showed that HIF1a binds to the Atf4 locus in
fCMs and RNA-seq and immunostaining analyses demonstrated
that Hif1a cKO hearts displayed increased transcription of Atf4
mRNA and increased levels of ATF4 protein, placing Atf4 as a
direct target of transcriptional repression by HIF1a. To examine
the contribution of ATF4-mediated transcription to the aberrant(F) Apoptotic mesenchymal cells were equally abundant in the atrioventricular (A-V
detected in the compact wall of either genotype.
Scale bars represent 500 mm in (A) and 50 mm in all other panels. LV = left ventricle
See also Figure S2.
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RNA-seq results with previously published ChIP-seq data for
ATF4. No CM-specific ATF4 ChIP-seq is available. However,
because ATF4 targets similar sets of genes in multiple cellular
contexts (Kilberg et al., 2009), we compared our RNA-seq results
with ATF4 targets as defined by ChIP-seq performed in mouse
embryonic fibroblasts (Han et al., 2013). Out of 494 genes upre-
gulated in Hif1a cKO hearts, 77 corresponded to loci previously
reported to be bound by ATF4 (Figure 5A; Table S5A). Consid-
ering the total of 413 loci bound by ATF4 (ChIP-seq), one would
expect the presence, just by chance, of 12 ATF4 targets in any
list of 494 genes randomly generated from the 14,502 genes ex-
pressed in E12.5 hearts. The observed 77 genes represent a very
significant enrichment in ATF4 targets among genes upregulated
in Hif1a cKOs (p < 0.0001), and Reactome analysis of these
revealed striking similarity to results for all genes upregulated
in Hif1a mutant hearts (Figures 4B and 5B), suggesting that
ATF4-mediated transcription contributes significantly to the
aberrant mutant transcriptome. Notably, of the 77 direct ATF4
targets upregulated in Hif1a cKO hearts, 17 were also bound
by HIF1a (Table S5E), suggesting that in addition to directly
blocking Atf4 expression, HIF1amay also directly regulate direct
targets of ATF4 activation. Consistent with the general percep-
tion of ATF4 as a transcriptional activator, and not a repressor
(Han et al., 2013), overlap between genes downregulated in
Hif1a cKO hearts and ATF4 targets was not significant (15 genes
observed versus 23 expected by chance; Figure 5A).
Intersection between HIF1a and p53 Pathways
Functional clustering of direct targets repressed by HIF1a using
Reactome was enriched in classes associated with signaling
downstream of p53 (Figure 4D), suggesting a regulatory interac-
tion between these two TFs. In contrast to ATF4, p53 did not
appear to be transcriptionally regulated by HIF1a, as its mRNA
levels were unchanged in Hif1a cKO hearts and our ChIP-seq
assay provided no evidence for HIF1a binding to the Trp53 locus
or vicinity. However, the gene encoding MIF, a well-character-
ized inhibitor of p53 post-translational activation (Fingerle-Row-
son et al., 2003; Hudson et al., 1999; Welford et al., 2006), was
directly bound by HIF1a (Figure S3E) and downregulated in
Hif1a cKO hearts, at both RNA and protein levels (Table S2D;
Figures 4E and S3E). The combined actions of DNA damage
(Schmid et al., 2004) andMif downregulation are likely to trigger
ectopic p53 activation.
After a similar informatics strategy to the one described for
ATF4, we looked for significant enrichment of direct targets of
p53 in the list of 1451 genes modulated in Hif1a cKO hearts by
comparing our RNA-seq results with previously published
ChIP-seq data for p53 in mouse embryonic fibroblasts (Kenzel-
mann Broz et al., 2013). Consistent with known activity of
p53 as a transcriptional repressor and activator (Schmid et al.,
2004), this analysis resulted in significant (p < 0.0001) intersec-
tion of direct targets of p53 with genes that were both upre-
gulated (77 observed versus 39 expected by chance) and) cushions of control andmutant hearts, but no evidence of apoptotic fCMswas
. In (B), (C), and (E), data are expressed as mean ± SD. **p < 0.01; ***p < 0.001.
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Figure 4. Identification of Direct HIF1a Targets in E12.5 fCMs
(A) Comparison of control and Hif1a cKO E12.5 cardiac transcriptomes (n = 3 for each genotype) unveiled a total of 1,451 genes modulated in mutant hearts.
(B) REACTOME database functional clustering of genes down- and upregulated in cKOs, highlighting cellular processes most significantly affected in mutant
hearts.
(C) Overlay of RNA-seq and ChIP-seq results revealed 166 likely direct targets of HIF1a.
(D) REACTOME functional clustering of these genes allowed the identification of cellular functions directly regulated by HIF1a. *Category containing the G1/S
transition inhibitor p21.
(E) Immunostaining validation of RNA-seq results in the left ventricular free wall or IVS (MIF) of E12.5 hearts.
Scale bars represent 20 mm. AA = amino acid; GPVI = glycoprotein VI. See also Figure S3 and Tables S2, S3, and S4.
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Figure 5. Intersections among HIF1a, ATF4, and p53
(A) Overlap between genes modulated inHif1a cKO hearts and ATF4 ChIP-seq data revealed a significant enrichment in ATF4 targets among upregulated genes.
(B) REACTOME functional clustering of ATF4 targets modulated in Hif1a cKO hearts.
(C) Overlap between genes modulated in Hif1a cKO hearts and p53 ChIP-seq data revealed a significant enrichment in p53 targets among both down- and
upregulated genes.
(D) REACTOME functional clustering of p53 targets modulated in Hif1a cKO hearts.
(E–G) Ex vivo culture of primary E12.5 ventricular cells in different oxygen concentrations revealed that hypoxia (3% O2) promoted an increase in fCM number.
This effect was associated with increased proliferation of troponin T-positive fCMs (F) and was dependent on HIF1a (G).
(legend continued on next page)
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downregulated (132 observed versus 77 expected by chance) in
Hif1a cKOs (Figure 5C; Tables S5B and S5C).
Targets of p53 upregulated in Hif1a cKO hearts corresponded
to functional classes associated with tRNA aminoacylation,
senescence, and respiratory electron transport (Figure 5D).
Examination of the full gene list (Table S5B) suggested that in
HIF1a-depleted fCMs, activated p53 may promote transcription
of genes encoding four cell-cycle blockers: p21, p57, GADD45a,
and TOB2. Of these, p21 and GADD45a are well-established
targets activated by p53 (Schmid et al., 2004).
Targets of p53 downregulated in Hif1a cKO hearts showed
enrichment in categories containing ECM proteins (Col1a1,
Col5a2, Col27a1, Fbln5, Lama2, and Lamc2) and their remodel-
ing enzymes (Lox, Plod2, P4ha1, and Adamts2) (Figure 5D).
Whether these genes are direct targets of repression by p53
has not been previously investigated, but our data are consistent
with this being the case. Importantly, overlap betweenHIF1a and
p53 targets (Table S5F) highlighted the fact that both TFs seem
to regulate critical targets involved in cell-cycle control (Cdkn1a,
Cdkn1c, and Tob2) and ECM fiber assembly (Plod2 and P4ha1).
HIF1a and p53 Exert Rheostatic Control over fCM
Proliferation
The foregoing analyses suggested that the hypoplastic pheno-
type of Hif1a cKOs was, at least in part, attributable to molecular
dynamics between HIF1a and p53. To gain mechanistic insight
into these interactions, we established a primary culture system
to mimic in vivo conditions. E12.5 mouse ventricles were disso-
ciated into single-cell suspensions, cultured for 72 hr in different
oxygen conditions, and assessed for proliferation. Culture in
hypoxia (3% oxygen), but not 9% or 17% oxygen, resulted in a
significant increase in fCM numbers (Figure 5E) that was associ-
ated with an increase in the percentage of proliferating (pH3-
positive) Troponin T-positive fCMs (Figure 5F).
Cells were then isolated from E12.5 Hif1afl/fl ventricles and
transduced with control LacZ-expressing adenovirus (Ad-LacZ)
or Cre-expressing adenovirus (Ad-Cre) to ablate Hif1a ex vivo.
qPCR and immunocytochemistry analyses demonstrated that
Ad-Cre efficiently excised the floxed Hif1a allele, promoting
depletion of HIF1a protein andmolecular alterations that recapit-
ulated those observed inHif1a cKO hearts, including ATF4 upre-
gulation and increased mitochondrial content and DNA damage
(Figures S4A–S4K). Increase in fCM numbers induced by culture
in 3% O2 was observed in Ad-LacZ, but not in Ad-Cre trans-
duced cells, demonstrating that the hypoxia-induced prolifera-
tion of fCMs was HIF1a dependent (Figure 5G). This observation
was confirmed by evaluation of mitotic rates following a 48 hr
culture in the presence of 2.5 mM EdU. Approximately 38% of
Ad-LacZ treated fCMs exhibited evidence of DNA replication
when cultured in 17% O2. Culture in 3% O2 significantly
increased this to 63%, and Ad-Cre mediated Hif1a depletion re-
verted the rate to 40% (Figure 5H). Importantly, simultaneous KO
of Hif1a and Trp53 restored fCM proliferation, indicating that(H) Blunted proliferation resulting from absence of HIF1a was further demons
simultaneous ablation of HIF1a and p53.
(I) ELISA quantification of p53-DNA binding revealed that during cardiogenesis p
In (E)–(I), data are expressed as mean ± SD. *p < 0.05; ***p < 0.05. See also Figu
DeveHIF1a drives proliferation in hypoxia, at least in part, by antago-
nism of p53 activity (Figure 5H). Similar results were obtained in
small interfering RNA (siRNA) knockdown experiments (Figures
S4L and S4M).
The idea that HIF1a promotes proliferation in hypoxia by pre-
venting p53 activation was further supported by ELISA quantifi-
cation of p53-DNA binding activity in extracts from developing
hearts at distinct stages (Figure 5I). These data revealed that,
during cardiogenesis, p53 activity was inversely correlated with
nuclear localization of HIF1a (Figure 2), with p53-DNA binding
being 10-fold higher at E16.5 than at E12.5. Interestingly, culture
of E12.5 fCMs for 48 hr in 3% O2 resulted in p53 activity levels
comparable with those found in freshly isolated E12.5 hearts,
whereas culture in 17%O2 increased p53 activity 5-fold, to levels
similar to those observed in E16.5 hearts (Figure 5I).
DISCUSSION
Hypoxia-mediated signaling has been a target of extensive ana-
lyses in multiple contexts, but the role of HIF1a in mammalian
cardiogenesis has remained controversial. Here, we presented
a series of experiments demonstrating that HIF1a is critical
for mid-gestational proliferation of a distinct subset of fCMs.
Prompted by an in silico screen (Figure 1), we described a highly
dynamic pattern of HIF1a accumulation in the nucleus of a
subset of fCMs from E11.5 to E15 (Figure 2), providing a detailed
examination of the localization of HIF1a at a subcellular level in
embryonic heart and unveiling a direct correlation between
nuclear HIF1a and the lack of an available blood supply (Figures
S1G and S1H).
The null Hif1aD allele used in our studies was generated by
germline excision of an exon encoding the DNA binding domain,
with no exogenous DNA sequences retained in the engineered
locus. Homozygous Hif1aD/D embryos exhibited myocardial hy-
poplasia, further supporting the idea that the hyperplastic heart
observed using the Hif1atm1Jhu allele might be an artifact arising
from the retention of a PGK-Neo cassette, an element known to
introduce significant phenotypic variability (Dunwoodie, 2009).
Efficient cardiac-specific HIF1a depletion was only achieved
using a very early myocardial recombinase (Nkx2-5-Cre) and re-
sulted in decreased fCM proliferation, hypoplastic ventricles,
and VSDs (Figure 3). In contrast, ablation with a later-acting
Cre, aMhc-Cre, did not result in effective depletion of HIF1a pro-
tein, with the result that embryos with ‘‘mutant’’ genotypes were
born at expected ratios and able to survive to adulthood.
Results from our characterization of control and mutant
transcriptomes, in conjunction with HIF1a ChIP-seq analyses
(Figure 4), showed that in fCMs, HIF1a acted preferentially as a
transcriptional activator (115 direct targets downregulated in
mutant hearts), but also worked as a direct transcriptional
repressor (51 direct targets upregulated in mutant hearts). Inter-
estingly, in 33% of candidate direct targets, HIF1a binding to
DNA was independent of an HRE. This percentage is similar totrated by quantification of EdU-positive fCMs and could be rescued by the
53 and HIF1a activity inversely correlated.
re S4 and Table S5.
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Figure 6. Model of Interactions among HIF1a, ATF4, and p53 in the Response to Hypoxic Stress
(A) In hypoxic WT fCMs, HIF1a potentiates proliferation by regulating myriad cellular functions: carbohydrate metabolism, ECM deposition, OXPHOS, the cell
cycle, and p53 and ATF4 signaling.
(B) In the absence of HIF1a, hypoxic fCMs failed to adapt their metabolism to low oxygen, ectopically activated ATF4 and p53 pathways, and upregulated
expression of inhibitors of cell cycle. As a consequence, these cells adopted a quiescent phenotype that led to arrested cardiac development.
Red arrows represent upregulation, and green arrows represent downregulation. TFs are circled and cellular processes are bold. Black lines represent tran-
scriptional regulation and blue lines represent post-translational interactions or effects. Dashed lines represent inactive interactions. See Figure S5 for a detailed
list of all genes involved in the cellular processes highlighted in this diagram.ones reported in previous HIF1a ChIP-seq studies (Tanimoto
et al., 2010). In addition to direct target regulation, HIF1a can
indirectly regulate gene expression programs by inducing tran-
scription of molecules (Mxi1 and Mif) that repress the activity
of other TFs (C-MYC and p53, respectively) (Welford et al.,
2006; Zhang et al., 2007). Schematic summaries of mechanistic
interactions are provided in Figures 6 and S5. Although intersec-
tion of HIF1a ChIP-seq with RNA-seq data yielded major
pathways directly regulated by HIF1a in fCMs, as confirmed by
immunostaining of tissue sections and cultured fCMs, it is518 Developmental Cell 33, 507–521, June 8, 2015 ª2015 Elsevier Inpossible that some genes with altered expression in Hif1a
cKOs as detected by our RNA-seq data set may reflect second-
ary alterations in non-fCM transcriptomes, owing to crosstalk
between affected fCMs and their neighboring cells.
p53 and proteins of the retinoblastoma (RB) and E2F families
play a critical role in controlling cell cycle. In the specific context
of cardiogenesis, ectopic activation of p53 in fCMs results in hy-
poplasia and arrested development (Grier et al., 2006), whereas
inactivation of RB and p130 results in excessive proliferation in
adult heart (MacLellan et al., 2005). Our data sets revealed thatc.
HIF1a did not directly regulate transcription of genes encoding
these proteins. However, HIF1a inhibited p53 post-translational
activation by inducing MIF accumulation and by suppressing
DNA damage (Figure 4E). These observations were supported
by ELISA quantification of p53/DNA binding, revealing an inverse
correlation between the presence of HIF1a and p53 activity, both
in vivo and in vitro. In primary cell cultures, KO of Trp53 could
restore proliferation of HIF1a depleted fCMs (Figure 5H), further
suggesting that relative levels of active HIF1a and p53 exert
rheostatic control over fCM proliferation. p53 blocks the cell
cycle, at least in part, by inducing expression of members of
the CIP/KIP family. Interestingly, our analyses revealed that in
fCMs, HIF1a and p53 shared the genes encoding p21 and p57
as common targets, albeit regulating them in opposite direc-
tions. HIF1a bound to DNA in the vicinity of Cdkn1a (p21) and
Cdkn1c (p57) and HIF1a depletion resulted in increased expres-
sion of these genes, demonstrating direct repression by HIF1a in
fCMs. Previous studies have shown that p21/Cdkn1a is acti-
vated by HIF1a in human cancer cell lines (Koshiji et al., 2004),
revealing that the effects of HIF1a on Cdkn1a transcription are
context dependent. p57 is abundant in trabecular fCMs of mid-
gestational heart and absent from fCMs of the compact layer
(Kochilas et al., 1999). Increased levels of p57 protein were
evident in compact layer fCMs of Hif1a cKO hearts (Figure 4E),
providing a direct link between HIF1a depletion and decreased
fCM proliferation.
In hypoxia, mitochondrial OXPHOS is inefficient and generates
ROS (Semenza, 2013). To avoid detrimental effects of these
compounds, HIF1a establishes a gene expression program
that promotes reduction of mitochondrial biomass, limits
OXPHOS, and prevents ROS production (Table S2G). fCMs of
Hif1a cKOs had higher mitochondrial content and increased
DNA damage, likely consequent to increased ROS production.
Concomitantly to repressing OXPHOS, HIF1a promoted expres-
sion of glycolytic enzymes, allowing sustained ATP production in
hypoxia. It is widely accepted that proliferative cells preferen-
tially use glycolysis for energy production, as this process gener-
ates metabolic products required for biosynthesis prior to cell
division (Vander Heiden et al., 2009). Thus, blunted expression
of glycolytic genes observed in Hif1a cKO hearts is likely to
contribute to the observed hypoproliferative phenotype.
Another significant outcome of our study was to highlight crit-
ical interactions between HIF1a and the TF ATF4. HIF1a and
ATF4 are both activated by hypoxia and regulate downstream
gene programs aimed at cellular adaptation to environmental
stresses. The two TFs converge on the induction of angiogen-
esis, sharing Vegf as common target (Roybal et al., 2005), but
analysis of their downstream targets clearly indicates that their
response strategies are distinct. Whereas HIF1a adapts energy
metabolism to low oxygen, preventing entry into a crisis situa-
tion, ATF4 works to mitigate the consequences of an ongoing
metabolic crisis. To do so, ATF4 promotes expression of genes
associated with functions such as protein folding, amino acid
uptake, and metabolism and activates pathways that promote
biosynthesis of glutathione, a powerful reducing agent that neu-
tralizes intracellular peroxides (Harding et al., 2003).
Our results demonstrated that, in hypoxic fCMs, HIF1a directly
binds and represses expression of Atf4, exerting a brake on the
crisis response. Hypoxia has previously been shown to activateDeveATF4 translation via PERK (Fels and Koumenis, 2006), but to our
knowledge, this is the first report of direct transcriptional regula-
tion of Atf4 by HIF1a. Additionally, our analyses revealed enrich-
ment in ATF4 binding sites within ChIP-seq peaks corresponding
to genes repressed by HIF1a (Table S4) and suggested HIF1a
binds and regulates a substantial proportion of genes activated
downstream of ATF4 (Table S5E). These observations suggest
a complex interplay between both TFs and, similar to the
HIF1a/p53 dichotomy, detailed titration of the relative impact
of HIF1a and ATF4 on common target expression will be the
subject of future studies.
Hyperoxia has recently been shown to promote neonatal CM
cell-cycle withdrawal (Puente et al., 2014), and in zebrafish, hyp-
oxia and HIF1a are involved in CM proliferation after ventricular
amputation (Jopling et al., 2012). Here, we have shown that
HIF1a directly regulates energy metabolism, cell cycle, ECM
deposition, p53 and ATF4 signaling to promote proliferation of
a distinct subset of fCMs located within non-vascularized
regions of the mid-gestational heart, reiterating that an environ-
mental variable (oxygen) can play a critical role in the regulation
of CM proliferation. Several adult heart pathologies are of an
ischemic nature, and HIF1a has previously been shown to
regulate angiogenesis in adult cardiac hypertrophy via induction
of Vegf, a function countered by p53-induced degradation of
HIF1a (Sano et al., 2007). It will be of future interest to study
the extent to which the non-angiogenic pathways described
here may play a role in such pathological conditions, to gain
greater insight into the therapeutic potential of targeting HIF1a
and intersecting pathways to harness the proliferative potential
of adult hypoxic CMs.
EXPERIMENTAL PROCEDURES
Animal Procedures and Phenotypic Analyses
All animal care was in compliance with NIH guidelines and institutional guide-
lines at the University of California, San Diego. The floxed Hif1a allele (Ryan
et al., 2000) and all other transgenic mouse lines used have been previously
described and are listed in Supplemental Experimental Procedures. To ensure
efficient recombination, the nullHif1aD allele, generated by germline ablation of
the floxed allele, was included in all crosses. Standard immunohistochemistry
techniques, described in detail in Supplemental Experimental Procedures,
followed by confocal microscopy imaging were used for detection of endoge-
nous HIF1a protein in cryosections of embryonic hearts and for phenotypic
characterization of mutant hearts. Timing of coronary perfusion by aortic blood
flow was determined by injection of fluorescent microspheres (Life Technolo-
gies) into the left ventricles of E13.5 and E14.5 embryos and assessment of
microsphere presence within developing coronary vessels. Proliferation of
fCMs in vivo and ex vivo was inferred by quantification of EdU (Life Technolo-
gies) incorporation. An unpaired Student’s t test was used to assess statistical
significance of quantitative differences between controls and Hif1a cKOs.
Bioinformatic Analyses and Molecular Biology
The list of publically available microarrays used in our initial bioinformatics
screen, as well as the strategy for clustering genes exhibiting similar expres-
sion dynamics, can be found in Supplemental Experimental Procedures.
Analysis of enrichment in known TF binding sequences in the promoter of
genes grouped in each cluster was performed using Whole Genome RVista
(Dubchak et al., 2013).
For trancriptome analyses, total RNA was extracted from E12.5 hearts using
Trizol (Life Technologies). For each genotype, three independent replicates,
each one corresponding to a single E12.5 heart, were sequenced on an Illu-
mina HiSeq2000. Reads were mapped using TopHat2 and Bowtie2 and differ-
entially expressed transcripts identified using AltAnalyze. For identification oflopmental Cell 33, 507–521, June 8, 2015 ª2015 Elsevier Inc. 519
genomic regions bound by HIF1a, nuclei were isolated from E12.5 hearts
previously crosslinked in 1.5% formaldehyde. Crosslinked chromatin was
sonicated to an average size of 200 bp, and DNA-HIF1a complexes were
precipitated using an anti-HIF1a antibody (Novus). 10 ng of ChIP DNA from
two biological replicates was used to create standard Illumina sequencing
libraries and processed for deep sequencing. Reads were mapped using
Bowtie2, and peak callingwas performed using Homer. Extensive descriptions
of these procedures and informatics analyses are provided in Supplemental
Experimental Procedures. Resulting RNA-seq and ChIP-seq data sets can
be accessed at GEO: GSE61209 and GSE61247. ELISA evaluation of p53-
DNA binding activity was performed using the TransAM p53 kit (Active Motif).
Isolation and Culture of E12.5 Ventricular Cells
E12.5 mouse ventricles were dissociated into single-cell suspensions using
trypsin and cultured in 17% or 3% oxygen. Quantification of fCM proliferation
was achieved by flow cytometry using antibodies against troponin T (Thermo
Scientific) and phosphoHistone3 (Millipore). Gene KOwas achieved using cells
isolated from homozygous floxed Hif1a or double homozygous floxed Hif1a;
Trp53 embryos and treatment with Cre or LacZ (control) expressing adenovi-
ruses. For gene knockdown, cells were transfected with siRNAs targeting
Hif1a or Trp53mRNAs using Dharmafect I Transfection Reagent (Dharmacon).
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